Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001891919 | SCV002147166 | uncertain significance | not provided | 2024-12-16 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 499 of the MME protein (p.Glu499Lys). This variant is present in population databases (rs201292663, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of Charcot-Marie-Tooth disease (PMID: 30415211; internal data). ClinVar contains an entry for this variant (Variation ID: 1379140). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The lysine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001891919 | SCV002578757 | uncertain significance | not provided | 2022-04-07 | criteria provided, single submitter | clinical testing | Reported as a heterozygous variant in a sporadic case of Charcot-Marie-Tooth in a 73 year old female in published literature (Lupo et al., 2018); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 34480178, 30415211) |